维普期刊资源整合服务平台（V6.5）

68篇 您的检索式：作者名="Arihiro K"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Loss of CD9 with expression of CD31 and VEGF in breast carcinoma, aspredictive factors of lymph node metastasis显示文摘	Arihiro K Kaneko M Fujii S	1998	Breast Cancer1998，5，2：	1
2	Down-regulationof KAI1 messenger RNA expression is not associated withloss of heterozygosity of the KAI1 gene region in lung adeno-carcinoma 显示文摘	Tagawa K Arihiro K Takeshima Y	1999	Jpn J Cancer Res1999，90，9：	1
3	Mutagenicity of aristolochic acid in the lambda/lacZ transgenic mouse (Muta-Mouse) 显示文摘	Arihiro K Takayoshi S Masamitsu H	2002	Murat Res2002，515，：	1
4	Down-regulation of KAI1 messenger RNA expression is not associated with loss of heterozygosity of the KAI1 gene region in lung adenocarcinoma显示文摘	TAGAWA K ARIHIRO K TAKESHIMA Y	1999	Jpn J Cancer Res1999，90，9：	1
5	Expression of CD31, Met/hepatocyte growth factor receptor and bone morphogenetic protein in bone metastasis of osteosarcoma 显示文摘	Arihiro K Inai K	2001	Pathol Int2001，51，2：	1
6	Relative expression levels of Th1 and Th2 cytokine mRNA are independent prognostic factors in patients with ovarian cancer显示文摘	Kusuda T Shigemasa K Arihiro K	2005	Oncol Rep2005，13，6：	1
7	Chemosensitization by STI571 targeting the platelet-derived growth factor/ platelet-derived growth factor receptor-signaling pathway in the tumor progression and angiogenesis of gastric carcinoma显示文摘	Kim R Emi M Arihiro K	2005	Cancer2005，103，9：	1
8	Role of vascular en-dothe- lial growth factor-C and-D mRNA in breast cancer显示文摘	Teramoto S Arihiro K Koseki M	2008	Hi-roshima J Med Sci2008，57，2：	1
9	Discordant HER2 status between primary breast carcinoma and recurrent/metastatic tumors using fluorescence in situ hybridization on cytological samples 显示文摘	Arihiro K Oda M Ogawa K	2013	Jpn J Clin Oncol2013，43，1：	1
10	Down -regulation of KAI1 messenger RNA expression is not associated with loss of heterozygosity of the KAI1 gene region in lung adenocarcinoma显示文摘	Tagawa K Arihiro K Takeshima Y	1999	Jpn J Cancer Res1999，90，：	1
11	Chemosensitization by STI571 targeting the platelet-derived growth factor/ platelet derived growth factor receptor signaling pathway in the tumor progression and angiogenesis of gastric carcinoma 显示文摘	Kim R Emi M Arihiro K	2005	Cancer2005，103，9：	1
12	Role of vascular endothelial growth factor-C and -D mRNA in breast cancer显示文摘	Teramoto S Arihiro K Koseki M	2008	Hiroshima J Med Sci2008，57，2：	1
13	Loss of CD9 with expression of CD31 and VEGF in breast carcinoma,as predictive factors of lymph node metastasis显示文摘	Arihiro K Kaneko M Fujii S Inai K	1998	Breast Cancer1998，5，2：	1
14	Relative expression levels of Thl and Th2 cytokine mRNA are independent prognostic factors in patients with ovarian cancer显示文摘	Kusuda T Shigemasa K Arihiro K	2005	Oncol Rep2005，13，6：	1
15	Stratifying the outcome after neoadjuvant treatment using pathological response classification by the Japanese Breast Cancer Society显示文摘	Mukai H Arihiro K Shimizu C	2016	Breast Cancer2016，23，1：	1
16	Efficacy of atorvastatin for the treatment of nonalcoholic steatohepatitis with dyslipidemia 显示文摘	Hyogo H Tazuma S Arihiro K	2008	Metabolism2008，57，12：	1
17	Chemosensitization b)STI571 targeting the platelet - derived growth factor/plate-let -derived growth factor receptor - signaling pathway inthe tumor progression and angiogenesis of gastric oarcino-ma显示文摘	Kim R Erni M Arihiro K	2005	Cancer2005，103，9：	1
18	Down regulation of KAI1 messenger RNA expression is not associated withloss of heterozygosity of the KAI1 generegion in lung adenovirus carcinoma 显示文摘	TAGAWA K ARIHIRO K TAKESHIMAY Y	1999	Jpn J Cancer Res1999，90，9：	1
19	Down-regulation of KAI1 messenger RNA expression is not associated with loss heterozygosity of the KAI1 gene region in lung adenocarcinoma显示文摘	Tagawa K Arihiro K Takeshima Y	1999	Jpn J Cancer Res1999，90，9：	1
20	Early-onset parkinsonism with diurnal fluctuation-clinical and pathological studies显示文摘	Yamamura Y Arihiro K Kohriyama T	1993	Rinsho Shinkeigaku1993，33，5：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示